For media inquiries, contact us at 508-357-7740 or email at firstname.lastname@example.org.
|2/22/17||Demi Lovato, Sunovion and Leading Advocacy Organizations Release Mental Health Documentary as Part of Be Vocal Initiative|
|1/28/17||Sunovion's Latuda® (lurasidone HCl) Receives FDA Approval to Treat Adolescents with Schizophrenia|
|1/14/17||Sunovion Announces Pivotal Study Results for Novel Drug Candidate Dasotraline Demonstrating Significantly Improved Attention Deficit Hyperactivity Disorder Symptoms in Children Compared to Placebo|
|1/13/17||Sunovion Announces Top-line Results from Studies Evaluating Dasotraline in Adults with Binge Eating Disorder and Attention Deficit Hyperactivity Disorder|